Latest Kaiser Health News Stories
Kaiser Health News, in collaboration with NPR, kicks off a series that will examine and decode your perplexing medical bills.
Elizabeth Moreno got hit with a $17,850 bill from a Texas lab after leaving a urine sample at her doctor’s office.
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.
Algorithms and other technologies are moving from research labs to hospitals and clinics to predict and combat disease.
The Trump administration rolled out a list of actions to attack drug prices, but most dance around the edges.
Clinicians can be so focused on fixing problems and saving lives that they often avoid talking to patients about their prognosis.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
The centers, which serve 27 million people, get about 20 percent of their funding from the federal government. But that revenue is slated to end on March 31.
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?
Popular DNA ancestry tests don’t always find what people expect. That’s because of how DNA rearranges itself when egg meets sperm — and the quirks of genetic databases.
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Paige Winfield Cunningham of The Washington Post discuss the short-term spending bill passed by Congress that reopened the federal government and funded the Children’s Health Insurance Program for six years. The panelists also discussed the health programs still awaiting funding, and the intersection of religion and women’s health services at the Department of Health and Human Services.
A KHN data analysis finds that the door of opportunities connecting Capitol Hill, the federal government and the drug industry likely spins in Big Pharma’s favor.
An onslaught of fires, shootings and storms across the country last year tested hospital readiness. Now, leaders are using their experiences to address shortcomings that surfaced amid the chaos.
Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.
The Seattle jurist finds that Olympus Corp. failed to properly disclose evidence that it knew of concerns about cleaning problems with its redesigned medical scopes years before they hit the market and were linked to dozens of deaths. The company maintains the devices were not defective and intends to appeal.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
In this episode of “What The Health?” — taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.
Agencies sometimes turn away Medicare beneficiaries with chronic health problems by incorrectly claiming Medicare won’t pay for their services, say patient advocates.
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.